Crispr Therapeutics AG (CRSP) — Net Asset Momentum
Crispr Therapeutics AG (CRSP) recorded a net asset momentum of -0.5% as of December 2025, with net assets of $1.92 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Crispr Therapeutics AG tangible book value ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Crispr Therapeutics AG Net Asset Momentum (2014–2025)
This chart tracks Crispr Therapeutics AG's year-over-year net asset growth across 12 annual reporting periods from 2014 to 2025. The most recent momentum reading is -0.5%, with net assets of $1.92 Billion USD as of December 2025. Read Crispr Therapeutics AG (CRSP) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Crispr Therapeutics AG (2014–2025)
The table below shows the complete annual net asset history for Crispr Therapeutics AG from 2014 to 2025, covering 12 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see CRSP stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $1.92 Billion | $2.27 Billion | $343.43 Million | ▼ -0.5% |
| 2024 | $1.93 Billion | $2.24 Billion | $309.95 Million | ▲ +2.6% |
| 2023 | $1.88 Billion | $2.23 Billion | $346.77 Million | ▲ +0.4% |
| 2022 | $1.88 Billion | $2.24 Billion | $367.58 Million | ▼ -21.8% |
| 2021 | $2.40 Billion | $2.75 Billion | $352.42 Million | ▲ +44.2% |
| 2020 | $1.66 Billion | $1.83 Billion | $163.73 Million | ▲ +77.2% |
| 2019 | $939.42 Million | $1.07 Billion | $127.33 Million | ▲ +139.5% |
| 2018 | $392.19 Million | $489.02 Million | $96.82 Million | ▲ +108.8% |
| 2017 | $187.83 Million | $271.35 Million | $83.51 Million | ▼ -19.3% |
| 2016 | $232.85 Million | $344.96 Million | $112.12 Million | ▲ +899.5% |
| 2015 | $-29.12 Million | $159.42 Million | $188.55 Million | ▼ -317.6% |
| 2014 | $-6.97 Million | $1.53 Million | $8.50 Million | — |